Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation
PLOS Biology · 16.09.2025 · 23 (9) · e3003364
DOI: 10.1371/journal.pbio.3003364 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 16.09.2025. Verfasst von Ana Luisa Dian und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Orsay, France. Hauptthemen laut MEDLINE: Hexokinase, Melanoma, RNA-Binding Proteins, Protein Biosynthesis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (Inserm), Agence Nationale de la Recherche (ANR).
Abstract (Originalsprache)
Although metabolic benefits of glycolysis have been extensively described in tumor cells, the extra-metabolic functions linked to this energetic pathway in tumor growth and cell proliferation have not been clearly established yet. Recently, some key glycolytic enzymes, such as glyceraldehyde-3-phosphate dehydrogenase and pyruvate kinase 2, were reported to regulate mRNA translation. Translational control of gene expression is considered as a critical effector in cancer biology, representing a highly promising area of research. Here, we report that Hexokinase 2 (HK2), a glucose kinase that catalyzes the first step of glycolysis at the outer mitochondrial membrane (OMM), is an RNA-binding protein (RBP) that regulates mRNA translation in melanoma cell lines. Polysome profiling experiments followed by RNA sequencing indicate that the translational regulation exerted by HK2 is partly independent of the metabolic status or the glycolytic pathway. We found that HK2 specifically regulates translation of the mRNA encoding SOX10, a transcription factor implicated in the regulation of tumor initiation, maintenance, and progression in melanoma. RNA-protein interaction assays, including CrossLinking ImmunoPrecipitation (CLIP), indicate that HK2 is an RBP whose interaction with RNA is independent of its enzymatic activity, its ability to bind glucose or its association with the OMM. HK2 directly interacts with the 5′ untranslated region (5′UTR) of the SOX10 mRNA through a stem-loop RNA secondary structure. Using RNA-protein proximity ligation assays and a fluorescence-based ribosome-bound mRNA mapping method, we found that high glucose conditions, which promote the release of HK2 from the OMM, induce an increase in HK2- SOX10 mRNA interaction and SOX10 mRNA translation in the cytoplasm. We further showed that HK2-dependent SOX10 mRNA translation is involved in melanoma cell proliferation and colony formation. Collectively, our data highlight a nonmetabolic function of HK2 acting as an RBP and translation regulator.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut Curie, PSL Research University, CNRS UMR 3348, INSERM U1278, Orsay, France.
- Université Paris-Saclay, CNRS UMR 3348, INSERM U1278, Orsay, France.
- Equipe labellisée Ligue contre le Cancer, Orsay, France.
- INSERM U.981, Gustave Roussy, Villejuif, France.
- Université Paris Sud, Université Paris-Saclay, Kremlin-Bicêtre, France.
- Head and Neck Oncology Department, Gustave Roussy, Villlejuif, France.
ORCID-Profile: Stéphan Vagner
Förderung
- Centre National de la Recherche Scientifique (CNRS)
- Institut National de la Santé et de la Recherche Médicale (Inserm)
- Agence Nationale de la Recherche (ANR)
- Horizon Europe Marie Sklodowska-Curie Actions (MSCA)
- Institut Curie
- Institut Gustave-Roussy
- CNRS
- Institut National de la Santé et de la Recherche Médicale
Zitieren
APA
Dian, A. L., Fabbri, L., Moya-Plana, A., Claps, G., Ferreira, J. C., Labbé, C. M., Quidville, V., Martineau, S., Baille, D., Besse, L., Messaoudi, C., Roy, S., Raynal, V., Baulande, S., Rabeh, W. M., Robert, C., & Vagner, S. (2025). Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation. PLOS Biology, 23(9), e3003364. https://doi.org/10.1371/journal.pbio.3003364
Vancouver
Dian AL, Fabbri L, Moya-Plana A, Claps G, Ferreira JC, Labbé CM, et al. Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation. PLOS Biology. 2025;23(9):e3003364. doi:10.1371/journal.pbio.3003364
BibTeX
@article{Dian2025,
author = {Dian, Ana Luisa and Fabbri, Lucilla and Moya-Plana, Antoine and Claps, Giuseppina and Ferreira, Juliana C and Labbé, Céline M and Quidville, Virginie and Martineau, Sylvain and Baille, Dorothée and Besse, Laetitia and Messaoudi, Cédric and Roy, Séverine and Raynal, Virginie and Baulande, Sylvain and Rabeh, Wael M and Robert, Caroline and Vagner, Stéphan},
title = {Hexokinase 2 is an RNA-binding protein that regulates mRNA translation independently of glycolysis and induces melanoma cell proliferation},
journal = {PLOS Biology},
year = {2025},
volume = {23},
number = {9},
pages = {e3003364},
doi = {10.1371/journal.pbio.3003364}
}
EUVIMED